Insider trade

Officer sold ~$284K of HIMS shares in the open market

Traded Apr 20, 2026 · Filed Apr 22, 2026

~$284K
Approx. value · 9,463 sh @ $30.00: 299K
Holds after · shares reported: −4.3%
stock since the trade · S&P 500 +9.3%, $31.01 → $29.67 on Oct 5

Why it stands out

Hims & Hers Health's Chief Legal Officer sold $284K of Hims & Hers Health shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Apr 20, 2026
Reporting period: Not applicable
Filed with the SEC: Apr 22, 2026

Officer$100K–$500KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$283,890

Shares × reported transaction price

Timing vs results

56 days after results of Feb 23, 2026, 21 days before results of May 11, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	−3.5%	+1.4%	−4.9%
30 days	−15.3%	+6.0%	−21.2%
90 days	+12.5%	+5.5%	+7.0%

Past results only. Not a forecast.

Source receipt

Record ID: 0001837817-26-000009
Filed / recorded: Apr 22, 2026, 9:24 PM UTC
Added to OQRO: Oct 6, 2026, 7:59 PM UTC
Parser: form4-xml-v2
Data quality: Verified: identifiers matched exactly
Issuer: Hims & Hers Health, Inc.
Issuer CIK: 1773751
Ticker: HIMS
Reporting person: Soleil Boughton
Relationship: Officer
Officer title: Chief Legal Officer
Security: Class A Common Stock
Table: Non-derivative (Table I)
Transaction date: Apr 20, 2026
Transaction code: S
Shares / units: 9,463
Price per share: $30.00
Acquired / disposed: Disposed (D)
Shares owned after: 299,368
Ownership form: Direct
Amendment: No

Footnotes from the filing

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2025 by the Reporting Person.

Around the same time

Patrick Harrison CarrollChief Medical Officer

Filed 5mo ago

435Derivative units

Traded May 20 · filed 2 days later

Compensation award — excluded from discretionary-purchase analysis.

More Official record

Christopher D PayneDirector

Filed 5mo ago

647Derivative units

Traded May 20 · filed 2 days later

Compensation award — excluded from discretionary-purchase analysis.

More Official record

David B WellsDirector

Filed 5mo ago

957Derivative units

Traded May 20 · filed 2 days later

Compensation award — excluded from discretionary-purchase analysis.

More Official record